Schindler Ps (0QO1)
London Exchange · UK · prices in GBP · close of 22 Oct 2026
Key indicators
| Last close | GBP 289.00 |
|---|---|
| 52-week range | 246.60 – 314.01 |
| Return, 1 month / 3 months | +9.7% / +13.6% |
| Return, 1 year / 3 years | −4.2% / +61.5% |
| Trend | Uptrend |
| RSI (14) | 81 |
| Volatility (1 year) | 20.7% |
| Worst drawdown (1 year) | -20.1% |
| Average daily value traded | 8.94M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Schindler is a Swiss company that designs, builds and maintains elevators, escalators and moving walkways. Its equipment moves people through office towers, apartment blocks, shopping centres, airports and other large buildings. The company also modernises existing installations and provides maintenance and repair services, working with building owners, developers and facility managers. Schindler is based in Ebikon, Switzerland, and operates across many countries through local subsidiaries and service branches.
Schindler Ps trades under the code 0QO1 on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Schindler Ps (0QO1) trades on the London Exchange in UK. It last closed at GBP 289.00 on 22 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 802 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.2% and over the last three months it rose 13.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.5% | ||
| From 52-week high | -7.2% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 13.6% | ||
| 6-month return | 6.2% | ||
| 12-month return, skipping the last month | -12.7% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.1% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 8.94M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +8.4% |
|---|---|
| 1 month | +9.7% |
| 3 months | +13.6% |
| 6 months | +6.2% |
| 1 year | −4.2% |
| 3 years | +61.5% |
| 5 years | +17.0% |
Signals
| 50-day / 200-day average | 260.73 / 271.33 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.25 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Mar 2026 | GBX 0.0600 |
| 27 Mar 2025 | GBX 0.0600 |
| 21 Mar 2024 | GBX 0.0100 |
| 30 Mar 2023 | GBX 0.0400 |
| 24 Mar 2022 | GBX 0.0400 |
| 25 Mar 2021 | GBX 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.